Inflammation in the central nervous system and Th17 responses are inhibited by IFN-γ-induced IL-18 binding protein

Journal of Immunology

Volumn 185, Issue 4, 2010, Pages 2458-2466

  Millward, Jason M ^a,b,c   Løbner, Morten ^b   Wheeler, Rachel D ^a   Owens, Trevor ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; GAMMA INTERFERON; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; VIRUS VECTOR; INTERLEUKIN 17; INTERLEUKIN-18 BINDING PROTEIN; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; INHIBITION KINETICS; MOUSE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TH1 CELL; TH17 CELL; ALLERGIC ENCEPHALOMYELITIS; ANIMAL; C57BL MOUSE; CELL LINE; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; FLOW CYTOMETRY; GENETICS; HELPER CELL; HUMAN; IMMUNOLOGY; INFLAMMATION; INTRASPINAL DRUG ADMINISTRATION; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL LINE; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; INJECTIONS, SPINAL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-18; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 77956897473     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902153     Document Type: Article

References (47)

1. Steinman, L. 2007. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13: 139-145.
2. Gutcher, I., and B. Becher. 2007. APC-derived cytokines and T cell polarization in autoimmune inflammation. J. Clin. Invest. 117: 1119-1127.
3. Komiyama, Y., S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177: 566-573. (Pubitemid 43939170)
4. Haak, S., A. L. Croxford, K. Kreymborg, F. L. Heppner, S. Pouly, B. Becher, and A. Waisman. 2009. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J. Clin. Invest. 119: 61-69.
5. Ferber, I. A., S. Brocke, C. Taylor-Edwards, W. Ridgway, C. Dinisco, L. Steinman, D. Dalton, and C. G. Fathman. 1996. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156: 5-7.
6. Krakowski, M., and T. Owens. 1996. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26: 1641-1646.
7. Suryani, S., and I. Sutton. 2007. An interferon-gamma-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis. J. Neuroimmunol. 183: 96-103. (Pubitemid 46204914)
8. Stromnes, I. M., L. M. Cerretti, D. Liggitt, R. A. Harris, and J. M. Goverman. 2008. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat. Med. 14: 337-342.
9. Lees, J. R., P. T. Golumbek, J. Sim, D. Dorsey, and J. H. Russell. 2008. Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis. J. Exp. Med. 205: 2633-2642.
10. Jander, S., and G. Stoll. 1998. Differential induction of interleukin-12, interleukin-18, and interleukin-1beta converting enzyme mRNA in experimental autoimmune encephalomyelitis of the Lewis rat. J. Neuroimmunol. 91: 93-99. (Pubitemid 28545248)
11. Prinz, M., and U. K. Hanisch. 1999. Murine microglial cells produce and respond to interleukin-18. J. Neurochem. 72: 2215-2218.
12. Wildbaum, G., S. Youssef, N. Grabie, and N. Karin. 1998. Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis. J. Immunol. 161: 6368-6374. (Pubitemid 28536013)
13. Gutcher, I., E. Urich, K. Wolter, M. Prinz, and B. Becher. 2006. Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation. Nat. Immunol. 7: 946-953.
14. Novick, D., S. H. Kim, G. Fantuzzi, L. L. Reznikov, C. A. Dinarello, and M. Rubinstein. 1999. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10: 127-136.
15. Paulukat, J., M. Bosmann, M. Nold, S. Garkisch, H. Kämpfer, S. Frank, J. Raedle, S. Zeuzem, J. Pfeilschifter, and H. Mühl. 2001. Expression and release of IL-18 binding protein in response to IFN-gamma. J. Immunol. 167: 7038-7043.
16. Veenstra, K. G., Z. L. Jonak, S. Trulli, and J. A. Gollob. 2002. IL-12 induces monocyte IL-18 binding protein expression via IFN-gamma. J. Immunol. 168: 2282-2287.
17. Bufler, P., T. Azam, F. Gamboni-Robertson, L. L. Reznikov, S. Kumar, C. A. Dinarello, and S. H. Kim. 2002. A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity. Proc. Natl. Acad. Sci. USA 99: 13723-13728.
18. Faggioni, R., R. C. Cattley, J. Guo, S. Flores, H. Brown, M. Qi, S. Yin, D. Hill, S. Scully, C. Chen, et al. 2001. IL-18-binding protein protects against lipopoly-saccharide- induced lethality and prevents the development of Fas/Fas ligand-mediated models of liver disease in mice. J. Immunol. 167: 5913-5920.
19. Fantuzzi, G., N. K. Banda, C. Guthridge, A. Vondracek, S. H. Kim, B. Siegmund, T. Azam, J. A. Sennello, C. A. Dinarello, and W. P. Arend. 2003. Generation and characterization of mice transgenic for human IL-18-binding protein isoform a. J. Leukoc. Biol. 74: 889-896.
20. Plitz, T., P. Saint-Mézard, M. Satho, S. Herren, C. Waltzinger, M. de Carvalho Bittencourt, M. H. Kosco-Vilbois, and Y. Chvatchko. 2003. IL-18 binding protein protects against contact hypersensitivity. J. Immunol. 171: 1164-1171.
21. Zaccone, P., J. Phillips, I. Conget, A. Cooke, and F. Nicoletti. 2005. IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse. Clin. Immunol. 115: 74-79.
22. Yatsiv, I., M. C. Morganti-Kossmann, D. Perez, C. A. Dinarello, D. Novick, M. Rubinstein, V. I. Otto, M. Rancan, T. Kossmann, C. A. Redaelli, et al. 2002. Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury. J. Cereb. Blood Flow Metab. 22: 971-978.
23. Cua, D. J., J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748.
24. Millward, J. M., M. Caruso, I. L. Campbell, J. Gauldie, and T. Owens. 2007. IFN-gamma-induced chemokines synergize with pertussis toxin to promote T cell entry to the central nervous system. J. Immunol. 178: 8175-8182.
25. Wheeler, R. D., S. P. Zehntner, L. M. Kelly, L. Bourbonnière, and T. Owens. 2006. Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis. Immunology 118: 527-538.
26. He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95: 2509-2514.
27. Kim, S. H., M. Eisenstein, L. Reznikov, G. Fantuzzi, D. Novick, M. Rubinstein, and C. A. Dinarello. 2000. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc. Natl. Acad. Sci. USA 97: 1190-1195.
28. Furlan, R., S. Pluchino, P. C. Marconi, and G. Martino. 2003. Cytokine gene delivery into the central nervous system using intrathecally injected non-replicative viral vectors. Methods Mol. Biol. 215: 279-289.
29. Fleming, K. K., J. A. Bovaird, M. C. Mosier, M. R. Emerson, S. M. LeVine, and J. G. Marquis. 2005. Statistical analysis of data from studies on experimental autoimmune encephalomyelitis. J. Neuroimmunol. 170: 71-84.
30. Shi, F. D., K. Takeda, S. Akira, N. Sarvetnick, and H. G. Ljunggren. 2000. IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells. J. Immunol. 165: 3099-3104.
31. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
32. Cua, D. J., and R. A. Kastelein. 2006. TGF-beta, a 'double agent' in the immune pathology war. Nat. Immunol. 7: 557-559.
33. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
34. Sutton, C., C. Brereton, B. Keogh, K. H. Mills, and E. C. Lavelle. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203: 1685-1691.
35. Furlan, R., E. Brambilla, F. Ruffini, P. L. Poliani, A. Bergami, P. C. Marconi, D. M. Franciotta, G. Penna, G. Comi, L. Adorini, and G. Martino. 2001. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronicprogressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J. Immunol. 167: 1821-1829.
36. Bailey, S. L., B. Schreiner, E. J. McMahon, and S. D. Miller. 2007. CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T (H)-17 cells in relapsing EAE. Nat. Immunol. 8: 172-180.
37. Greter, M., F. L. Heppner, M. P. Lemos, B. M. Odermatt, N. Goebels, T. Laufer, R. J. Noelle, and B. Becher. 2005. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11: 328-334.
38. Harrington, L. E., R. D. Hatton, P. R. Mangan, H. Turner, T. L. Murphy, K. M. Murphy, and C. T. Weaver. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132.
39. Weaver, C. T., L. E. Harrington, P. R. Mangan, M. Gavrieli, and K. M. Murphy. 2006. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24: 677-688.
40. Weaver, C. T., R. D. Hatton, P. R. Mangan, and L. E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25: 821-852.
41. Boraschi, D., and C. A. Dinarello. 2006. IL-18 in autoimmunity: review. [review] Eur. Cytokine Netw. 17: 224-252.
42. Korn, T., E. Bettelli, W. Gao, A. Awasthi, A. Jäger, T. B. Strom, M. Oukka, and V. K. Kuchroo. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448: 484-487.
43. Batten, M., J. Li, S. Yi, N. M. Kljavin, D. M. Danilenko, S. Lucas, J. Lee, F. J. de Sauvage, and N. Ghilardi. 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7: 929-936.
44. Schif-Zuck, S., J. Westermann, N. Netzer, Y. Zohar, M. Meiron, G. Wildbaum, and N. Karin. 2005. Targeted overexpression of IL-18 binding protein at the central nervous system overrides flexibility in functional polarization of antigen-specific Th2 cells. J. Immunol. 174: 4307-4315.
45. Xiang, Y., and B. Moss. 1999. IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins. Proc. Natl. Acad. Sci. USA 96: 11537-11542.
46. Symons, J. A., E. Adams, D. C. Tscharke, P. C. Reading, H. Waldmann, and G. L. Smith. 2002. The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model. J. Gen. Virol. 83: 2833-2844.
47. Reading, P. C., and G. L. Smith. 2003. Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity. J. Virol. 77: 9960-9968.